Logo image of 2INV.DE

2INVEST AG (2INV.DE) Stock Fundamental Analysis

Europe - FRA:2INV - DE000A3H3L44 - Common Stock

12.6 EUR
-0.2 (-1.56%)
Last: 10/31/2025, 1:48:56 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 2INV. 2INV was compared to 76 industry peers in the Biotechnology industry. 2INV has an excellent financial health rating, but there are some minor concerns on its profitability. 2INV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year 2INV was profitable.
2INV had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 2INV reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: 2INV reported negative operating cash flow in multiple years.
2INV.DE Yearly Net Income VS EBIT VS OCF VS FCF2INV.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

With an excellent Return On Assets value of 29.93%, 2INV belongs to the best of the industry, outperforming 95.95% of the companies in the same industry.
With an excellent Return On Equity value of 30.46%, 2INV belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
The Return On Invested Capital of 2INV (22.40%) is better than 95.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 2INV is in line with the industry average of 12.82%.
The 3 year average ROIC (11.84%) for 2INV is below the current ROIC(22.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 29.93%
ROE 30.46%
ROIC 22.4%
ROA(3y)-1.72%
ROA(5y)11.4%
ROE(3y)-1.65%
ROE(5y)11.58%
ROIC(3y)11.84%
ROIC(5y)16.55%
2INV.DE Yearly ROA, ROE, ROIC2INV.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

2INV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2INV.DE Yearly Profit, Operating, Gross Margins2INV.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K 40K 60K 80K

More info and screens

9

2. Health

2.1 Basic Checks

The number of shares outstanding for 2INV has been reduced compared to 1 year ago.
The number of shares outstanding for 2INV has been reduced compared to 5 years ago.
There is no outstanding debt for 2INV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2INV.DE Yearly Shares Outstanding2INV.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
2INV.DE Yearly Total Debt VS Total Assets2INV.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 25.60 indicates that 2INV is not in any danger for bankruptcy at the moment.
2INV's Altman-Z score of 25.60 is amongst the best of the industry. 2INV outperforms 94.59% of its industry peers.
2INV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.6
ROIC/WACCN/A
WACCN/A
2INV.DE Yearly LT Debt VS Equity VS FCF2INV.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

2INV has a Current Ratio of 41.87. This indicates that 2INV is financially healthy and has no problem in meeting its short term obligations.
2INV's Current ratio of 41.87 is amongst the best of the industry. 2INV outperforms 100.00% of its industry peers.
A Quick Ratio of 41.87 indicates that 2INV has no problem at all paying its short term obligations.
2INV has a Quick ratio of 41.87. This is amongst the best in the industry. 2INV outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 41.87
Quick Ratio 41.87
2INV.DE Yearly Current Assets VS Current Liabilites2INV.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 415.47% over the past year.
EPS 1Y (TTM)415.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%231.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
2INV.DE Yearly Revenue VS Estimates2INV.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 5M 10M 15M
2INV.DE Yearly EPS VS Estimates2INV.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.79 indicates a rather cheap valuation of 2INV.
2INV's Price/Earnings ratio is rather cheap when compared to the industry. 2INV is cheaper than 97.30% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.11, 2INV is valued rather cheaply.
Industry RankSector Rank
PE 2.79
Fwd PE N/A
2INV.DE Price Earnings VS Forward Price Earnings2INV.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
2INV.DE Per share data2INV.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

2INV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

2INVEST AG

FRA:2INV (10/31/2025, 1:48:56 PM)

12.6

-0.2 (-1.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-13 2025-08-13
Earnings (Next)02-26 2026-02-26
Inst Owners0.39%
Inst Owner ChangeN/A
Ins Owners80.18%
Ins Owner ChangeN/A
Market Cap72.45M
Revenue(TTM)N/A
Net Income(TTM)25.93M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.79
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)4.51
EY35.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.59
FCFYN/A
OCF(TTM)-2.59
OCFYN/A
SpS0
BVpS14.8
TBVpS14.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number38.76
Profitability
Industry RankSector Rank
ROA 29.93%
ROE 30.46%
ROCE 31.82%
ROIC 22.4%
ROICexc 29.58%
ROICexgc 29.58%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.72%
ROA(5y)11.4%
ROE(3y)-1.65%
ROE(5y)11.58%
ROIC(3y)11.84%
ROIC(5y)16.55%
ROICexc(3y)17.54%
ROICexc(5y)53.02%
ROICexgc(3y)17.54%
ROICexgc(5y)53.04%
ROCE(3y)16.81%
ROCE(5y)23.52%
ROICexgc growth 3Y188.36%
ROICexgc growth 5YN/A
ROICexc growth 3Y188.36%
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 41.87
Quick Ratio 41.87
Altman-Z 25.6
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)415.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%231.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y217.89%
EBIT growth 3Y216.03%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-279.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-279.65%
OCF growth 3YN/A
OCF growth 5YN/A

2INVEST AG / 2INV.DE FAQ

What is the fundamental rating for 2INV stock?

ChartMill assigns a fundamental rating of 4 / 10 to 2INV.DE.


Can you provide the valuation status for 2INVEST AG?

ChartMill assigns a valuation rating of 2 / 10 to 2INVEST AG (2INV.DE). This can be considered as Overvalued.


What is the profitability of 2INV stock?

2INVEST AG (2INV.DE) has a profitability rating of 4 / 10.


What is the financial health of 2INVEST AG (2INV.DE) stock?

The financial health rating of 2INVEST AG (2INV.DE) is 9 / 10.